Search
for
Sort by
Research 31–60 of 1000+
- Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia
- Objective evaluation of photoepilation by phototrichogram
- Targeted Follicular Delivery via Liposomal Encapsulation of Sesbania grandiflora - Enhances Hair and Scalp Health: A Randomized, Double-Blind, Placebo-Controlled Clinical Study
- Efficacy and Safety of L-Cystine Associated or not to a Natural Keratin (Kera-Dietandreg;) Hydrolysate on Hair and Nails: Randomised, Placebo-Controlled, Clinical Trial on Healthy Females
- Evaluation of hair growth
- Effect of minoxidil formulations on human scalp skin xenotransplants on SCID mice – a novel pre‐clinical in vivo assay for androgenetic alopecia research
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Efluvio telógeno: uma sequela pos-COVID 19
- Telogen effluvium with dysesthesia has lower B12 levels and may respond to B12 supplementation
- Relationship Between Helicobacter pylori Infection and Vitiligo: A Prospective Study
- A comparison of vertical versus transverse sections in the evaluation of alopecia biopsy specimens
- An analysis of canine hair re‐growth after clipping for a surgical procedure
- Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan
- Teledermatology: An updated overview of clinical applications and reimbursement policies
- The changes in the hair cycle during gestation and the post-partum period
- Evaluation of platelet‐rich plasma plus basic fibroblast growth factor combined with minoxidil in the treatment of androgenetic alopecia: A randomized controlled trial
- Telogen Effluvium – a review of the science and current obstacles
- Nanocrystal Structure of Minoxidil: A Safe Stimulator for Hair Growth Factor for C57BL/6 Mice
- Telogen Effluvium Associated With Weight Loss: A Single Center Retrospective Study
- Commonly prescribed medications associated with alopecia
- 392 Hair loss after drug reaction with eosinophilia and systemic symptoms: A multicentric retrospective study
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomised, double-blinded, placebo-controlled clinical trial
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- The inductive effect of ginsenoside F2 on hair growth by altering the WNT signal pathway in telogen mouse skin
- Telogen Effluvium: A Review of the Literature
- COVID ‐19 induced telogen effluvium
- A surge in the incidence of telogen effluvium in minority predominant communities heavily impacted by COVID-19
- Postpartum telogen effluvium
- Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium
- Use of 5% Topical Minoxidil Application for Telogen Effluvium: An Open‐Label Single‐Arm Clinical Trial